The German billionaire Dietmar Hopp owns the most shares of CureVac, followed by the Bill and Melinda Gates Foundation, which works with the company to develop vaccines against a number of infectious diseases. In his rejection of Trump's offer, Hopp indirectly criticized the U.S. president on Sunday evening as lacking solidarity: "Once we, hopefully soon, succeed in developing an effective vaccine against the coronavirus, it should reach, protect and help people not only regionally but in the spirit of solidarity around the world."
